Santiago, Chile

Constanza Sigala

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Phytotox Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Constanza Sigala. Retrieved from https://idiyas.com/inventor/constanza-sigala-t5uuk76b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Constanza Sigala: Innovator in Sensory Treatment

Introduction

Constanza Sigala is a prominent inventor based in Santiago, Chile. She has made significant contributions to the field of medical treatments, particularly focusing on sensory disorders. Her innovative work has the potential to improve the quality of life for many individuals suffering from sensory loss.

Latest Patents

Constanza holds a patent for a sodium channel blocker designed for the treatment of loss of superficial sensitivity. This invention addresses the reduction or loss of the sense of touch in humans and other mammals. The development of this sodium channel blocker represents a significant advancement in therapeutic options for sensory disorders.

Career Highlights

Constanza is currently associated with Phytotox Limited, where she continues to work on groundbreaking research and development. Her dedication to innovation in the medical field has established her as a key figure in her area of expertise.

Collaborations

Constanza collaborates with notable colleagues, including Max Rutman and Jean J Pilorget. These partnerships enhance her research efforts and contribute to the advancement of her projects.

Conclusion

Constanza Sigala's work in developing a sodium channel blocker showcases her commitment to addressing sensory loss. Her contributions to the field of medical innovation are invaluable and highlight the importance of continued research in this area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…